• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Swoop® system

Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced initial findings from the multicenter observational study Assessing Brain Injury Using Portable Magnetic Resonance Imaging in Patients With Extracorporeal Membrane Oxygenation.

Read more →
Tru Niagen Pro 1,000mg

ChromaDex Debuts Clinical Strength Tru Niagen® Pro 1,000mg Featuring Niagen®

ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) research and healthy aging, launches its clinical strength Tru Niagen® Pro 1,000mg, featuring 1,000mg of Niagen® (patented Nicotinamide Riboside or NR), one of the most efficient and superior quality NAD+ precursors on the market, to consumers nationwide.

Read more →
Hexainnoheal

Hexainnoheal develops new home-use medical device 'Flexible PainQ'

Home-use medical device manufacturer Hexainnoheal has been gaining recognition for its pain therapy products. Hexainnoheal manufactures healthcare devices using Low Level Lasers and LED lighting. Its primary product line-up includes PainQ for pain management and CobiQ for rhinitis management. Hexainnoheal also focuses on developing a new product called Flexible PainQ.

Read more →